T he presence of transient ST depression (STD) on ECG monitoring of patients with clinical coronary heart disease has been shown to be reflective of ischemia.12 A natural concern is whether this makes a significant contribution to mortality when other prognostic variables are taken into account. To answer that question among patients who survived a myocardial infarction (MI), we conducted a large case-control study using data from the completed Beta Blocker Heart Attack Trial (BHAT) . Methods
Study Population and Study Design
The BHAT was a double-blind, randomized trial of the effects of propranolol on survival after acute MI.3 The total group numbered 3,837 patients aged 30-69.
Patients were excluded from the study if they had medical contraindications to propranolol, a history of severe congestive heart failure or asthma as an adult, or if they had or were likely to undergo cardiac surgery. Clinical and personal characteristics and ECG data, including the results of 24-hour ECG monitoring from the baseline reference examination, were completed while patients were hospitalized before randomization. Patients were followed for a minimum of one and up to three years after index MI.
There were 326 deaths during the BHAT follow-up period. We used a time-matched case-control design,4 with the case group consisting of 261 patients who died and for whom readable tapes were available. The pool of eligible controls or risk set for each case (i.e., death) consisted of individuals who eventually may have died or survived the trial but must have survived at least as long as the given case. One control was randomly selected from the eligible pool for each case. The matching criteria were age at enrollment (exact to the year), sex, drug status, and length of follow-up. Intermittent STD is defined as an STD maintained for at least 1 minute at a time.
BHAT Tapes
Five electrode sites were used to record two bipolar Vl-and Vs-like ECG leads from the right subclavicular space to V5 position (lead CV5) and from the left subclavicular space to V, position (lead CV1) with an Avionics Model 445 two-channel reel-to-reel continu-ous ambulatory ECG recorder. This recorder had a low-frequency response of 0. er's identification of the PR segment for each QRS displayed in the 20-second strip. If the visual assessment agreed with the computer, the ST deviation was confirmed; if not, the ST deviation was labeled false. We required that >50% beats in the-sample agree with the visual determination before the ST episode was confirmed. When computer-generated STD strips equaled or exceeded 5 minutes, samples for reader verification were taken from the beginning, middle, and end. A set of 30 random plots was examined for each subject to provide a check of false-negative detection.
Limitations ofAmbulatory Monitoring and Computer Methodology
The ambulatory ECG recording methodology used in 
Results

Prevalence
The prevalence of STD was 21% (25% in deaths, 19% in controls). This overall prevalence was identical to that found in an earlier pilot study of 100 patients randomly selected from the entire BHAT population. The prevalence of STD>30 minutes was 8% (10% in deaths, 6% in controls).
Prognosis
In the basic matched-pairs analysis, of the total of 261 pairs, 100 were discordant for STD Table 3 (nongradient model), it is evident that in the presence of propranolol, STD has no impact on mortality, whereas it does have a significant effect, RR, 2.56 (1.39-4.71), among those taking placebo.
We also investigated the possibility that STD might influence mortality differentially in those with and without a history of angina by introducing an interaction term to the previous regression model. Deaths matched to controls on time, age, sex, and drug status. RR estimates adjusted for previous myocardial infarction (MI), diastolic blood pressure, heart rate, cigarette smoking before MI, and presence of pulmonary edema. a model including STD,, STD30, respective drug interaction terms, and covariates (Table 3 , gradient model), STD, regardless of category, continued to have no impact on mortality in treated patients. In the untreated group, however, the respective RRs for STD of 1-30 minutes and >30 minutes were 1.91 (0.92-3.96) and 4.33 (1.60-11.71). A two-tailed test for trend was significant (p=0.001), providing evidence for a gradient of risk. In this model, history of previous MI, increased heart rate, or cigarette smoking before MI continued to elevate risk significantly.
In Table 4 (gradient model), we examined the interaction between history of angina and STD in the context of the gradient model. The effect of history of angina in untreated patients was to enhance the dose-response effect of STD on mortality. The studies"",2 and 30% in a selected high-risk post-MI population.13 The lower prevalence of STD in the BHAT population may well reflect BHAT's exclusion of patients with severe heart failure and those who were potential surgical candidates.
Performance of the 24-hour monitoring 7-21 days after acute MI may have contributed to the lower prevalence. About half the deaths and controls were monitored 6-9 days after MI. The distributions of deaths and controls in the 7-21-day interval were overall quite similar, and the respective median time intervals after MI were identical (8 days). Any postulated difference on the effect of monitoring interval on STD prevalence would not be likely to influence the difference in mortality observed between the two groups.
There have been few reports on the impact of STD on mortality after MI. One such study involving a small number of deaths among a subgroup of high-risk MI patients showed a positive association.13 In other studies, the small numbers followed did not permit a reliable assessment of mortality. 14 The results reported here are consistent with an independent contribution to mortality by the presence of STD of .1-minute duration when other relevant variables are taken into account. A gradient is evidenced by the increase in risk associated with the presence of more than 30 minutes of STD and again when an interaction occurs in the presence of history of angina. Finally, the effect is greatest when these abnormalities are present in the placebo group compared with the propranolol group.
The size of this study yielded a sufficiently large number of deaths to develop a number of statistical models from which to determine the best-fitting model. A limitation of the current study is the absence of refined measures of left ventricular function. The presence of congestive heart failure with acute MI, however, was a strong independent risk factor. It is also to be noted that intermittent STD is not synonymous with "silent ischemia," because patient diaries were not recorded. There is abundant evidence, however, that the majority of STD episodes in a variety of settings are unaccompanied by symptoms.'5 We found no effect on mortality from the presence of ST elevation; both similar and contradictory reports have been made by others.16 '17 Approximately one sixth of the BHAT deaths were unavailable for analysis, mainly because of the lack of a readable 24-hour tape. To investigate possible selection bias, we compared baseline characteristics of both groups and found no appreciable differences. The limitations of the BHAT ambulatory monitoring and the computer methodology used have been noted in the "Methods" section. Any bias introduced would be random and would have the effect of underestimating the true RRs. Digitalis use and left ventricular hypertrophy can affect the ST segment, but their presence made no independent contribution to mortality. The location of MI was examined as a possible cause of bias, because STD was found to be more prevalent in inferior wall than anterior wall MI. Despite the increased number of deaths with anterior wall MI compared with controls, the location of MI did not influence the effect of STD in the multivariate model. This may be because of the 40% of deaths who had both anterior and inferior wall MI.
Chronic angina occurring among patients recovered from MI is not independently related to mortality. '8 Therefore, it is of interest to find an interaction between history of angina before MI and intermittent STD, which is independently predictive of mortality. It would be of importance to determine whether these relations are also characteristic of post-MI angina. If so, it would be possible to differentiate a particularly high-risk subgroup.
There have been few studies of prognosis of patients with angina in the absence of MI. In one such study, fixed STD on ECG was found to be an independent predictor of mortality, together with age and ventricular arrhythmia.19 Fixed STD is also a significant independent risk factor after MI with or without angina.20-22 The mechanism is not known, but it is likely that this ECG abnormality reflects discrete anatomical change in the heart and is thereby related to muscle dysfunction. 23 The work of Maseri24 has shown that intermittent STD in angina patients, whether accompanied by pain or not, is often caused by transient impairment of regional blood flow rather than by an excessive increase in myocardial demand. The inciting factors leading to impairment of flow are not known but are likely to be varied, including mental stress. 25 Psychosocial factors have been shown to increase the risk of dying after MI, and an examination of their influence on intermittent STD would therefore be of interest.2' More recently, it has been shown that silent ischemic episodes are frequently preceded by an increase in heart rate and blood pressure, suggesting that increase in myocardial oxygen demand also plays a role.27 This has particular implication to mechanisms by which propranolol might exert an anti-ischemic effect.
We found that the independent contribution to mortality by STD was present primarily in the placebo group. These data suggest the possibility that propranolol blunts the effects of STD on mortality and invite speculation about additional mechanisms of propranolol effectiveness. The finding that ventricular arrhythmia was suppressed in a randomly selected group of 1,000 patients who had a repeat 6-week monitoring in the BHAT study suggested that an antiarrhythmic mechanism partially explained propranolol's effect.28 Metopropol is known to have an anti-ischemic effect,29 but to date there has been no demonstration that this effect has significant influence on survival. The current data showing that the propranolol-treated group is less affected than the placebo group by intermittent STD are important but are only indirect evidence that the antiischemic effect may also be an independent contributor to survival. More information on factors responsible for transient ischemia would be useful in planning controlled trials to explore whether suppression of intermittent STD by drugs or other means might increase survival among recovered MI patients.
